Inf’OGM est une veille citoyenne qui œuvre pour une véritable transparence du débat OGM.
Soutenez-nous en utilisant le moteur de recherche éthique Lilo. C’est gratuit et si tous nos lecteurs utilisaient Lilo, nous pourrions boucler notre budget. Mille mercis !
REJOIGNEZ LILO ET DONNEZ-NOUS VOS GOUTTES

inf'ogm

Citizen information watchdog on GMOs and seeds

  • français
  • español
  • Facebook
  • Twitter
  • Instagram
  • Linkedin
  • Youtube
  • GMOs
  • New GMOs
  • Forçage génétique
  • Main issues
  • Legislation
  • Labelling and public information
  • Patent
  • Seed

home une

GMO: EFSA suggests to restrict the meaning of “transgenic”

On June 7, 2023, the European Commission might propose a modification of the regulatory framework for GMOs. Its goal is to have GMO obtained by “directed mutagenesis and cisgenesis” excluded from the requirements of labelling and risk assessment, which would concern only transgenic GMOs. But, according to the European experts, the very notion of “transgenic” could also be modified in order to further restrict the number of GMOs concerned by, among other things, this risk assessment and labelling.

Three-parent babies: GMO babies?

Three-parent in vitro fertilisation (IVF), which came out of the laboratories in 2015, is intended to solve certain hereditary diseases. Sometimes referred to as “mitochondrial donation”, this practice, which is better known abroad than in France, regularly returns to the forefront of the media [1] [2] Are the children born from this IVF, with genetic contributions from two women and one man, not GMOs?

Mini-guide ‪‬| To the rescue ? Can GMOs really help the global south ?

n°170, janvier - mars 2023

Inf'OGM the newspaper is a three-monthly 28 pages providing critical and contextualized informations on GMO news and seeds.

Support an independent information
subscribe.

Last news

For EFSA, risk analysis of GMOs must become the exception
New GMOs: a deleterious link between regulation and patents
New GMOs - Greenpeace raises awareness among consumers
  • Suivre l’actualité
  • Soutenez-nous !
  • Cart’OGM
  • Agenda
  • Boutique
  • OGM autorisés en Europe
  • Adhésion
  • Vidéos
  • FAQ
  • Patentability Can the Unified Patent Court be impartial? - December 2022
  • Area Europe: transgenic crops never stop dying - November 2022
  • Patentability « GMO-herbicides » duo: long-term industrial prospects - November 2022
  • non transgenic GMO GMOs: will the CJEU uphold its 2018 ruling? - November 2022
  • non transgenic GMO GMOs: the corporate communication department to the rescue - November 2022
  • Labelling GMO label will remain partial in the US - October 2022
  • non transgenic GMO FSC label: towards acceptance of GMO trees? - September 2022
  • non transgenic GMO Objective 2030: deregulate most GMOs in Europe? - September 2022
  • Patentability EU - UPOV : free trade agreements vs. food security - September 2022
  • Innovation Bioprinted organs and tissues : where do we stand? - September 2022

Read the news published the last 12 months

  • Who are we?
  • Actions
  • Mission et valeurs
  • Qui nous finance ?
  • Equipe et Conseil d’Administration
  • Rapports d’activités et financiers
  • Press room
  • Contact
  • Site Map
  • Boutique
  • Mentions légales
  • Facebook
  • Twitter
  • Youtube
  • Instagram
  • LinkedIn
Inf'OGM

All our articles are published under a Creative Commons licence

23 visitors now